Business Context and Reporting Period
Company: The Joint Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 9, 2017
Reporting Period: Specific event date (May 9, 2017); not a periodic financial report.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes
The material change reported is the Board of Directors' approval of the 2017 Executive Short-Term Incentive Plan (2017 Executive STIP) on May 9, 2017. Key features include:
- Eligible Participants: President and CEO, and Chief Financial Officer.
- Performance Metric: Awards are contingent on achieving Target Adjusted EBITDA for 2017.
- Bonus Pool Calculation: 70% of each dollar in excess of Target Adjusted EBITDA is added to the bonus pool.
- Award Composition: 50% cash and 50% Restricted Stock Awards (RSAs).
- Vesting: All RSAs vest immediately on the date of grant.
- Maximum Awards:
- CEO: Not to exceed 50% of base salary.
- CFO: Not to exceed 40% of base salary.
Guidance, Outlook, and Risks
Management Commentary: The stated purpose of the plan is to incentivize management to materially improve the performance of company-owned and franchised clinics and to control costs, thereby significantly improving Adjusted EBITDA.
Target Metrics: The specific Target Adjusted EBITDA figures for 2017 are established by the Compensation Committee but are not disclosed in this filing.
Risks/Contingencies: Compensation is contingent on performance; if Target Adjusted EBITDA is not achieved, no cash or RSAs will be awarded under this specific plan.
Investor Verification Checklist
- Verify the specific Target Adjusted EBITDA figures established by the Compensation Committee (not disclosed in this text).
- Confirm the maximum dollar amount allocated to the Combined Pool by the Compensation Committee.
- Review the company's 2017 financial results to determine if the performance targets were met.
- Check subsequent filings for the actual number of RSAs granted and the stock price on the grant date.